Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Video game therapy shows promise for kids with cerebral palsy

NCT ID NCT07325981

Symptom relief Sponsor: Ziauddin University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares three types of physical therapy for 90 children aged 6-12 with mild cerebral palsy: traditional therapy, active video games (exergaming), and exergaming with real-time muscle feedback. The goal is to see which approach best improves movement, balance, and motivation. Results could lead to more engaging and effective rehab for kids.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 90 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Dec 2025

An estimate. Start dates often move.

Expected to finish

Aug 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

6 to 12 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Diagnosed with Cerebral Palsy (CP), specifically spastic diplegia, spastic hemiplegia, or mild ataxia. * Gross Motor Function Classification System (GMFCS) Level I or II. * Male and female aged between 6 and 12 years at the time of enrollment. * Manual Ability Classification System (MACS) Level I or II. * Able to follow simple two-step commands, with or without augmentative and alternative communication (AAC). * Demonstrates adequate cognitive functioning based on the NIH Toolbox Picture Sequence Memory Test (PSMT), scoring at or above the 25th percentile (T-score ≥ 40) based on age-adjusted norms. * Hearing and vision adequate to participate in exergaming tasks (with or without assistive devices). * Able to stand and participate in basic movements with or without minimal assistance. * Willingness to participate and written informed consent from parent/guardian with assent from the child. Exclusion Criteria: * GMFCS Level III or higher, indicating significant gross motor limitations. * MACS Level III or higher, indicating significant manual impairment. * Severe uncorrected visual or hearing impairment that would interfere with interaction during exergaming. * Uncontrolled epilepsy or other neurological condition contraindicating active movement. * Significant behavioral or attention challenges that prevent engagement with game-based tasks. * Score below the 25th percentile on the PSMT, indicating insufficient episodic memory to follow game tasks. * Involvement in any other intervention trial that may interfere with study participation. * Medical conditions that contraindicate participation in physical activity (as determined by a physician).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cerebral palsy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cerebral palsy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cerebral palsy

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Ziauddin University

    Karachi, Sindh, 75850, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.